Literature DB >> 6601492

Candida endophthalmitis in a heroin addict: a case report.

J F Salmon, B M Partridge, D J Spalton.   

Abstract

Metastatic candida endophthalmitis presented as a unilateral panuveitis in an apparently healthy drug addict. Diagnosis was confirmed by vitrectomy. The eye made an excellent response to treatment with the new antifungal drug, ketoconazole, and 5-fluorocytosine. Problems raised in the diagnosis and management of this infection are discussed.

Entities:  

Mesh:

Year:  1983        PMID: 6601492      PMCID: PMC1040048          DOI: 10.1136/bjo.67.5.306

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  18 in total

1.  Endogenous fungal endophthalmitis in a drug addict.

Authors:  R A Getnick; M M Rodrigues
Journal:  Am J Ophthalmol       Date:  1974-05       Impact factor: 5.258

Review 2.  Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis.

Authors:  J E Edwards; R Y Foos; J Z Montgomerie; L B Guze
Journal:  Medicine (Baltimore)       Date:  1974-01       Impact factor: 1.889

3.  Antifungal chemotherapy.

Authors:  J Cohen
Journal:  Lancet       Date:  1982-09-04       Impact factor: 79.321

Review 4.  Strategies in the treatment of systemic fungal infections.

Authors:  G Medoff; G S Kobayashi
Journal:  N Engl J Med       Date:  1980-01-17       Impact factor: 91.245

5.  Candida endophthalmitis after intravenous drug abuse.

Authors:  G L Aguilar; M S Blumenkrantz; P R Egbert; J P McCulley
Journal:  Arch Ophthalmol       Date:  1979-01

6.  Tetrazolium medium as an aid in the routine diagnosis in Candida.

Authors:  M J Denny; B M Partridge
Journal:  J Clin Pathol       Date:  1968-05       Impact factor: 3.411

7.  Pars plana vitrectomy in the management of endogenous Candida endophthalmitis.

Authors:  R C Snip; R G Michels
Journal:  Am J Ophthalmol       Date:  1976-11       Impact factor: 5.258

8.  Ocular penetration of 5-fluorocytosine.

Authors:  A Walsh; D A Haft; M H Miller; M R Loran; A H Friedman
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-07       Impact factor: 4.799

9.  Mycotic endophthalmitis in drug abusers.

Authors:  J H Elliott; D M O'Day; G S Gutow; S F Podgorski; P Akrabawi
Journal:  Am J Ophthalmol       Date:  1979-07       Impact factor: 5.258

10.  The structural basis of altered vascular permeability following intraocular inflammation.

Authors:  E L Howes; V K Cruse
Journal:  Arch Ophthalmol       Date:  1978-09
View more
  5 in total

1.  Candida endophthalmitis: clinical presentation, treatment and outcome in 23 patients.

Authors:  S Schmid; A C Martenet; O Oelz
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

2.  Mixed haematogenous endophthalmitis caused by Candida albicans and CDC fermentative corynebacterium group A-4.

Authors:  C Barker; J Leitch; N P Brenwald; M Farrington
Journal:  Br J Ophthalmol       Date:  1990-04       Impact factor: 4.638

3.  Metastatic Staphylococcus aureus endophthalmitis: a case report.

Authors:  C J O'Brien; G M Kyle
Journal:  Br J Ophthalmol       Date:  1988-03       Impact factor: 4.638

4.  The place of elective vitrectomy in the management of patients with Candida endophthalmitis.

Authors:  T Barrie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

5.  Toxicity of intravitreal oxiconazole.

Authors:  J A Schulman; G A Peyman; J Dietlein; R Fiscella
Journal:  Int Ophthalmol       Date:  1989-05       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.